← Back to Search

Imaging Device

Retinal Imaging using the OSNAT800 IO device for Diabetic Retinopathy

N/A
Waitlist Available
Research Sponsored by PulseMedica
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new camera called the OSNAT800 IO that takes 3D pictures of the back of the eye and tracks eye movements in real-time. It aims to help doctors monitor patients with diabetic retinopathy, a common cause of vision loss. The goal is to see if this device can accurately track eye movements while taking detailed images.

Eligible Conditions
  • Diabetic Retinopathy
  • Retinal Imaging

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Successful performance of the real-time eye tracking function by post-image processing
Secondary study objectives
Device usability as assessed by a survey
Image Quality as assessed by user assessment of image quality parameters

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Retinal Imaging using the OSNAT800 IO deviceExperimental Treatment1 Intervention
Patients will have their eyes imaged with the OSNAT800 IO device in addition to a routine standard of care appointment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
OSNAT 800 IO
2022
N/A
~60

Find a Location

Who is running the clinical trial?

PulseMedicaLead Sponsor
2 Previous Clinical Trials
275 Total Patients Enrolled
~19 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top